• Drug-Sensitized Yeast for mTOR Inhibitor Discovery

  2026-10-06

  A 2025 GeroScience study developed a genetically drug-sensitized Saccharomyces cerevisiae platform for detecting TOR/mTOR pathway inhibitors with substantially greater sensitivity than a wild-type yeast background. The system distinguished known inhibitors, identified aminophylline as a TOR1-dependent growth inhibitor, and found no evidence of TOR inhibition for several tested compounds, including nebivolol, within the assay model.

• CUDC-907 Product Overview

  2026-10-06

  CUDC-907 (SKU A4097) is an APExBIO research product described as a dual PI3K and HDAC inhibitor. The supplied materials establish its product identity and conceptual cancer-research scope, but no matched paper evidence is available to independently validate performance or applicability.

• Adefovir Dipivoxil in Chronic HBV: Evidence and Mechanism

  2026-10-05

  Hadziyannis and Papatheodoridis synthesized preclinical and clinical evidence positioning adefovir dipivoxil as an oral nucleotide analog antiviral for chronic hepatitis B, including HBeAg-positive, HBeAg-negative, and lamivudine-resistant disease. The review’s central contribution is its connection of selective HBV DNA polymerase inhibition with durable virologic activity, relatively low resistance, and the need to interpret long-term safety in relation to renal function.

• Canagliflozin and Mitochondrial Kidney Research

  2026-10-05

  A source-grounded overview of how canagliflozin was associated with proximal-tubule mitochondrial remodeling in hypertensive–diabetic mice, what the findings suggest about renal protection, and why the evidence remains preclinical and model-specific.

• ddhCTP and Viperin: From Mechanism to Translation

  2026-10-04

  A source-grounded analysis of ddhCTP, viperin biology, flaviviral RNA synthesis interruption, and the emerging evidence that viperin can also suppress coronavirus replication through nsp8-dependent disruption of replication-transcription complex assembly.

• Anagliptin: From DPP-4 to Vascular Tone

  2026-10-03

  Anagliptin and SK-0403 are best known for selective DPP-4 inhibition, but recent rabbit-aorta evidence points to a distinct vascular smooth-muscle phenotype. This article evaluates the Kv channel and SERCA findings, separates established results from interpretation, and defines the translational limits of the evidence.

• Cardamomin and Oxidative Stroke Injury

  2026-10-02

  The reference study shows that cardamomin from Amomum villosum stems and leaves protects against hydrogen peroxide-induced oxidative injury in BV-2 cells and reduces damage in a rat model of permanent cerebral ischemia. Its main innovation is a mechanistic framework connecting MEK/ERK-dependent NRF2 activation with suppression of oxeiptosis, parthanatos, DNA damage, and tissue injury.

• Go 6983 and the Logic of PKC-Centered Translation

  2026-10-01

  Translational research increasingly depends on connecting signaling perturbations with cell fate and metabolism rather than treating each phenotype as an isolated endpoint. This thought-leadership article examines how Go 6983, a pan-PKC inhibitor, can be used to interrogate PKC-dependent biology while placing recent WDR36–glycolysis findings in the proper evidentiary context.

• ML385 and NRF2: A Translational Research Playbook

  2026-10-01

  ML385 offers a practical way to interrogate NRF2-dependent stress adaptation, ferroptosis, and therapeutic resistance. This thought-leadership guide connects evidence from non-small cell lung cancer research with ferroptosis-focused liver studies and outlines a disciplined path from pathway inhibition to translational insight.

• InstaBlue Protein Stain Solution in Cell Assays

  2026-09-30

  This scenario-based guide explains how InstaBlue Protein Stain Solution, SKU B8226, can strengthen protein-level quality control alongside cell viability, proliferation, and cytotoxicity assays. It covers compatibility, rapid staining, interpretation limits, safety, and vendor-selection criteria using product specifications and relevant biomedical literature.

• 7ACC2 and the Metabolic Logic of Tumor Lactate

  2026-09-30

  7ACC2 is a potent monocarboxylate transporter 1 inhibitor that connects lactate flux, mitochondrial pyruvate handling, radiosensitization, and emerging tumor–immune metabolic biology. This thought-leadership perspective interprets its preclinical evidence, outlines validation strategies, and explains how researchers can position 7ACC2 within translational cancer metabolism research without overstating its clinical maturity.

• Intestinal Stretch, Weight Loss, and Satiety Recovery

  2026-09-29

  A 2025 Molecular Metabolism study shows that intestinal stretch suppresses feeding and improves oral glucose tolerance through mechanisms that are not dependent on GLP-1 signaling or classical intestinal nutrient sensing. Obesity weakened this response, whereas dietary and surgical weight loss restored stretch-responsive neuronal activity, highlighting gut mechanosensation as a distinct and potentially reversible metabolic pathway.

• Ceftazidime Workflows for Resistance Research

  2026-09-29

  Ceftazidime connects standardized susceptibility testing with plasmid-localization and transmission studies in clinically relevant Gram-negative models. This practical guide shows how to build reproducible assays for Pseudomonas aeruginosa and carbapenem-resistant Enterobacter cloacae while avoiding common formulation and interpretation errors.

• 5-(N,N-dimethyl)-Amiloride: NHE1 Workflows

  2026-09-28

  Build cleaner intracellular pH regulation, endothelial permeability, and cardiac ion-transport assays with 5-(N,N-dimethyl)-Amiloride hydrochloride. Its strong NHE1 preference supports mechanistic dose-response studies, while careful vehicle controls and orthogonal readouts help separate exchanger inhibition from broader metabolic effects.

• Adefovir (GS-0393): HBV and OAT1 Workflows

  2026-09-28

  Adefovir (GS-0393) supports two distinct research workflows: measuring HBV polymerase inhibition and probing OAT1-mediated transport. This guide connects dose selection, aqueous handling, assay controls, and troubleshooting while keeping structural biology findings in their proper context.

8097 records 1/540 page Next 12345 下5页 Last page